Results 131 to 140 of about 1,789 (171)

Ring-ing in the Future: Participant and Male Partner Perspectives Regarding Future Use of the Dapivirine Vaginal Ring for HIV Prevention. [PDF]

AIDS Behav, 2022
Reddy K, Mathebula F, Katz A, Luecke E, Tenza S, Palanee-Phillips T, Garcia M, Mansoor LE, Naidoo S, Morar N, Chitukuta M, Tsidya M, Montgomery ET, MTN-032 Study team.   +13 more
europepmc   +1 more source

Use of Pharmacokinetic Data in Novel Analyses to Determine the Effect of Topical Microbicides as Preexposure Prophylaxis Against HIV Infection. [PDF]

, 2015
Vermund, SH, Walker, AS
core   +1 more source

Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial. [PDF]

AIDS Behav, 2021
Mayo AJ, Browne EN, Montgomery ET, Torjesen K, Palanee-Phillips T, Jeenarain N, Seyama L, Woeber K, Harkoo I, Reddy K, Tembo T, Mutero P, Tauya T, Chitukuta M, Gati Mirembe B, Soto-Torres L, Brown ER, Baeten JM, van der Straten A, MTN-020/ASPIRE study team.   +19 more
europepmc   +1 more source

Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial. [PDF]

AIDS Behav, 2022
Etima J, Katz AWK, Duby Z, Garcia M, Palanee-Phillips T, Reddy K, Mathebula F, Zimba C, Mansoor LE, Singh D, Manengamambo E, Naidoo S, Soto-Torres L, Montgomery ET, MTN-020/ASPIRE, MTN 025/HOPE, MTN-032 Study teams.   +16 more
europepmc   +1 more source

The PrEP Ring Quarterly—Edition 3, July 2025 [PDF]

This is the third edition of The PrEP Ring Quarterly newsletter, which provides information, updates, and resources dedicated to the dapivirine vaginal ring (DVR) also known as PrEP ...
IPM South Africa
core  

Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother-infant pairs (MTN-043): a phase 3B, open-label, randomised trial. [PDF]

Lancet HIV
Noguchi LM, Owor M, Mgodi NM, Gati Mirembe B, Dadabhai S, Horne E, Gundacker H, Richardson BA, Bunge K, Scheckter R, Song M, Marzinke MA, Anderson PL, Livant E, Jacobson C, Piper JM, Chakhtoura N, Hillier SL, Balkus JE, MTN-043 Study Team.   +19 more
europepmc   +1 more source

A Review and Economic Analysis of the Dapivirine Vaginal Ring as HIV Pre-Exposure Prophylaxis for Women, to Inform South African Public-Sector Guidelines. [PDF]

J Acquir Immune Defic Syndr
Leong TD, Nel J, Jamieson L, Osih R, Dawood H, Subedar H, McCaul M, Johnson LF, Cohen K.   +8 more
europepmc   +1 more source

Acceptability of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) during Pregnancy in Malawi, South Africa, Uganda, and Zimbabwe. [PDF]

AIDS Behav
Young AM, Stoner MCD, Mathebula F, Mohuba R, Baez A, Seyama L, Mutero P, Etima J, Fabiano Z, Fairlie L, Mayo AJ, Balkus JE, Song M, Bunge K, Piper J, Balan IC, van der Straten A, Montgomery ET.   +17 more
europepmc   +1 more source

DELIVER: A Safety Study of a Dapivirine Vaginal Ring and Oral PrEP for the Prevention of HIV During Pregnancy. [PDF]

J Acquir Immune Defic Syndr
Bunge K, Balkus JE, Fairlie L, Mayo AJ, Nakabiito C, Mgodi N, Gadama L, Matrimbira M, Chappell CA, Piper J, Chakhtoura N, Szydlo DW, Richardson B, Hillier SL.   +13 more
europepmc   +1 more source

Acceptability of the Dapivirine Vaginal Ring and Oral Truvada Among African Users in Late-Stage of Pregnancy. [PDF]

AIDS Behav
Montgomery ET, Hawley I, Fairlie L, Bunge K, Mathebula F, Etima J, Mutero P, Senyama L, Mayo A, Stoner MCD, Piper J, Balan I, van der Straten A.   +12 more
europepmc   +1 more source